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When Wolbach and Howe (1) studied vitamin A-deficient rats in the Twenties,
they notedamongthemany histopathologicchanges amarked atrophy of the thymus
and loss oflymphoid cells in spleen and lymph nodes . Subsequent observations re-
vealed that avitaminotic birds develop deficient bursas (2), and that avitaminotic
rats reared conventionally, as opposed to under germ-free conditions, suffer from
multiple, life-threat,ming infections (3) . These findings may have signalled the pos
sibility that lymphopoiesis is compromised in vitamin A deficiency, but a formal
connection to the physiology ofimmune cells has not been established . Despite sporadic
evidence in the literature (reviewed in references 4 and 5) that retinoids influence
immune responses, to our knowledge systematic studies to uncover the mechanism
underlying immune system enhancement have not been carried out .
In the course of studies of a growth factor for human, EBVtransformed B lym-
phocytes, we have isolated a lipid-like molecule by extraction ofserum with organic
solvents . We show in the present report that this low molecular weight factor consists
ofall-trans retinol . The finding that vitaminA supports the growth of culturedhuman
B cells has not previously been reported . It may be related to growth stimulation
ofepithelial cell lines by retinoids although there are several reports to the contrary
(for review, see reference 6), demonstrating growth inhibition by retinoids . We had
previously isolated a protein on the basis of its ability to stimulate the proliferation
oflymphoblastoid cells grown at low density (7) . The bioactivity of this protein was
markedly enhanced by a lipid cofactor. Wenow know that the protein factor represents
the monomer subunit of prealbumin (PA)' (unpublished results), and that the lipid
cofactor is retinol . PA (8) is one of two protein molecules of a complex endowed
with the task of transporting retinol in the blood, the other being retinol-binding
protein (RBP) (9) . Retinol binds to RBP, conferring high binding affinity for PA
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to the latter (10, 11). The trimolecular complex thus formed serves as the physiologi-
cally active form of vitamin A in blood plasma (9). We have searched for RBP in
our B cell stimulatory factor and have confirmed that for full bioactivity RBP is
indeed required. In the present report we give an account ofour finding that retinol
in conjunction with carrier proteins is essential for growth of activated B cells in culture.
Materials and Methods
Retinoids.
￿
Retinoids were purchased from Sigma Chemical Co. (St. Louis, MO). The
retinoids were dissolved at a concentration of 3 x 10-2 M in methanol/chloroform (3:1
vol/vol) with 10-4 M butylated hydroxytoluene (BHT) (Sigma Chemical Co.) added and
stored in the dark at -20°C in a nitrogen atmosphere. Immediately before a bioassay, the
stock solutions were diluted in serum-free medium (HB101 ; Hana Biologics, Berkeley, CA).
Cells.
￿
The human EBVtransformed lines 5/2, Ducaf, PLH, Pitout, Thomas, BH, and
Mou were established in our laboratory from the peripheral blood of healthy donors. The
cells were tested regularly for mycoplasma infections and were consistently negative. B cells
were prepared from normal human spleens by Ficoll gradient centrifugation followed by OKT4
and OKT8 (Ortho Pharmaceutical, Raritan, NJ) antibody treatment plus rabbit comple-
ment and passage through a Sephadex G-10 column. Recovered cells contained >90% sIg'
cells. 5 x 105 cells/ml were activated either with 0.03% of fixed Staphylococcus aureus Cowan
strain (SAC) or 4 lAg/ml of F(ab')2 fragments of rabbit anti-human Ig (Tago Inc., Burlin-
game, CA) in HB101 medium (Hana Biologics) 48 h before the beginning of the experiment.
Standard B Cell Proliferation Assay.
￿
The assay system is a modification of the assay devel-
oped by Blazar et al. (12). Lymphoblastoid cells grown for 18-24 h in serum-free HB101 medium
at a cell density of 4 x 105 cells/ml or B cells activated by SAC or anti-t. for 48 h were washed
twice. The cells were then plated at graded cell concentrations in a final volume of 200 /Al/well
of HB101 in 96-well microtiter plates and grown for 72 h. Cell growth was determined by
labeling the cells for the last 16 h with 0.8,uCi/well of [3H]thymidine (sp act 6.7 Ci/mmol).
Cell Growth Curves.
￿
Lymphoblastoid 5/2 cells were washed once and seeded at a concen-
tration of 300,000/ml with or without 10-6 M retinol in HB101 medium in 25-cm2 tissue cul-
ture flasks (Corning Glass Works, Corning, NY). Three aliquots of 100 pl were removed at
24-h intervals, and thymidine uptake was determined by culturing in the presence of 0.8 ACi
of [3H]thymidine for an additional 6-h period. To determine the viable cell number, nine
aliquots per time point were removed and counted in a Neubauer chamber. Dead cells were
determined by the uptake of trypan blue.
Delipidation of Serum Protein.
￿
LPS-free FCS was purchased from HyClone Laboratories
(Logan, UT), and human plasma was produced from whole blood obtained from the New
York Blood Center. The serum or plasma was stirred overnight at -20°C in a 100-fold volume
excess of diethylether/ethanol 1 :3 (vol/vol). Precipitated proteins were washed twice in
diethylether, dried, redissolved in PBS, and dialyzed extensively against PBS.
Isolation ofSerumLipids.
￿
100 ml ofhuman plasma or FCS was freeze dried. The dry powder
was extracted twice with 40 ml ofchloroform/methanol 2 :1 (vol/vol) followed by two extrac-
tions with 40 ml of chloroform/methanol/water 10 :10:1 (vol/vol). All solvents contained
10-4 M BHT. The combined extracts were dried on a rotary evaporator. Lipids were dis-
solved in chloroform/methanol/water 10:10:1 (vol/vol) and stored at -80°C. Immediately
before a bioassay, aliquots of the lipid solution were evaporated to dryness and the residual
lipids dispersed in HB101 medium by sonication.
Lipid Separation on a Reversed-phase HPLC Column.
￿
An HPLC system (M6000 solvent delivery
pump, model 400 wavelength detector, data module, and data processor; Waters Associates,
Milford, MA) was used. The crude lipid mixture was loaded on a semipreparative reversed-
phase C,s HPLC column (Vydac; The Separations Group, Hesperia, CA). Lipids were
eluted with a linear gradient of water/methanol/chloroform. The gradient started with
water/methanol 70:30 (vol/vol), went in 30 min to 100% methanol, and in another 30 min
to methanol/chloroform 50 :50 (vol/vol). The flow rate was 3 ml/min. The elution profile was
monitored at wavelengths of 280 and 340 nm.BUCK ET AL.
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Mass Spectrometry.
￿
Bioactive lipid fractions were stored at -80°C under nitrogen. Elec-
tron impact (EI) and either methane or isobutane chemical ionization (CI) mass spectra of
the samples were obtained by loading the samples on a direct insertion probe ofa VG 70-250
double-focusing mass spectrometer. The probe was slowly heated so that the antioxidant ad-
ditive BHT volatilized first, followed by the lipid material.
Isolation ofRetinol-retinolBindingProteinComplex(13).
￿
40 mg ofhumanprealbumin was cova-
lently bound to 3 ml ofCNBr-activated sepharose. 50 ml ofhuman plasma was passed through
the column. The column was washed with 30 ml of 0.04 M Tris HCl (pH 7.4)/0.5 MNaCl
and eluted with 1-ml incrementsofdistilled water. Purity was established by SDS-PAGE with
silver stain using the PhastSystem by Pharmacia Fine Chemicals (Piscataway, NJ). The op-
tical densities at 280 and 340 nm were determined.
Results
Serum as Growth Promoter ofActivatedHuman B Cells.
￿
Human B cells transformed
by EBV grow in defined serum-free HB101 medium at high cell density (>100,000
cells/ml). However, when removed from high cell density serum-free conditions after
1 d ofculture, washed in serum-free medium, and reseeded in fresh HB101 medium
at low density, the cells proliferate at a much lower rate and, if the average density
falls below 104 cells per culture well (5 x 104 cells/ml), most of the cells die within
24 h. Suitable growth conditions are restored by the addition ofhuman serum (Table
I), FCS (data not shown), or our own conditioned medium of high density human
lymphoblastoid cells grown in serum-free HB101 medium (12, 30, data not shown).
SerumLipids or Delipidated Serum Proteins AlonePossess Moderate Growth-stimulatory Ca-
pacity but Act in Synergy to Enhance B Cell Growth. Serum lipids were isolated from
human serum by solvent extraction with diethylether/ethanol or chloroform/meth-
anol/water mixtures. The growth stimulatory effects of lipids and delipidated pro-
teins (i.e., the residue after ether/ethanol extraction) for EBVtransformed cells were
tested either alone or in combination. The results ofTable I show that either compo-
nent alone produces a definite, though modest increase in thymidine uptake. When
the lipid and protein fractions were added together, a synergistic effect occurred that
nearly matched the growth stimulation potential of whole serum.
Characterization ofthe GrowthpromotingHumanSerumLipid.
￿
The bioactivity oflipids
TABLE I
Comparison of Growth-stimulating Effect between Human Serum,
Delipidated Serum Proteins, andSerum Lipids
Stimulating agent
￿
Growth-stimulating effect
cpm
Plain HB101
￿
1,952 t 138
Human serum (3%)
￿
16,896 t 232
Delipidated serum proteins
￿
4,094 t 772
Serum lipid
￿
4,360 t 266
Protein + lipid
￿
13,211 t 721
Washed 5/2 cells (1,500/well) were incubated for 72 h in serum-free HB101 medi-
um. DNA synthesis was assessed by a 16-h [3H]thymidine uptake. The experi-
ment was done in triplicate. Purified proteins and lipids were reconstituted to
concentrations equivalent to those of 3 % serum. The data correspond to the
mean t SD .1616
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decayed within hours at room temperature, but decay could be slowed by the addi-
tion of the antioxidant BHT and by storage of the sample in the dark at -80°C
in a nitrogen atmosphere . The lipid mixture was chromatographed on a reversed-
phase C18 HPLC column (Fig. 1) with linear water/methanol/chloroform gradient .
Analysis of the fractions in the bioassay showed that 80% oftotal activity was recov-
ered in fraction 34 . Corresponding to the main bioactivity peak was an optical ab-
sorption peak registering at the wavelengths of 280 and 340 nm . The material col-
lected in this fraction fluoresced when exposed toUV light . The EI and CI mass
spectra of the bioactive component (fraction 34 in Fig . 1) indicated the presence of
a single compound with a molecular mass of 286 daltons . The EI spectrum, shown
in Fig . 2 A, shows the molecular ion peak at mass to charge ratio (m/z) 286, major
fragment ion peaks at m/z 268 and 255, and a series of low mass ions indicative
ofa highly unsaturated hydrocarbon . A computer search of the National Bureau
of Standards library spectra showed a good fit with the spectrum of all-trans retinol,
which is shown in Fig. 2 B . Accordingly, authentic all-trans retinol was applied to
thebioassay, and a growth-enhancing effect was observed on activatedhumanB cells
similar in magnitude to the ones elicitedby bioactiveHPLC fraction 34 or the crude
serum lipid (Table II, see below) . When all-trans retinol was chromatographed on
theHPLC Cta column, the bulk of the material was recovered at the same position
(i .e ., fraction 34) as the main bioactivitypeak obtained from the lipid mixture . Frac-
tions 30, 36, and 38-41 in Fig. 1 also contained bioactivity, but their biochemical
nature hasyetto be determined .A second series ofexperiments with FCS gave similar
results, identifying all-trans retinol as the major bioactive component .
Retinol-Retinol Binding Protein Complex Serves as Growth Factor .
￿
In serum, the nat-
ural carrier of retinol is RBP complexed with PA (9) . The trimolecular complex
FIGURE 1 .
￿
RP-HPLC . Crude lipids from 500ml human serum were loaded on a semiprepara-
tive reversed-phase CIeHPLC column . Lipids were eluted with a linear gradient ofwater/meth-
anol/chloroform, The flow rate was 3 ml/min. The elution was monitored by absorption at 280
nm(-), and each 1-min fraction was tested for bioactivity in the standard B cell growth assay
as described in Materials and Methods .BUCK ET AL.
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TABLE II
Comparison of Growth-stimulating Effect of Human Serum, Retinol,
and Purified Lipid on Activated Human B Cell Blasts
Growth-stimulating effect
FIGURE 2 .
￿
(A) EI mass spec-
trum of the bioactive fraction
no. 34 (Fig . 1) . (B) El mass spec-
trum ofall-imns retinol from the
National Bureau of Standards
library.
EBV blasts
(5/2 cell line)
(1,500/well)
1,451 t 366
10,446 t 1,021
6,136 t 213
6,910 t 1,015
Washed B cell blasts were incubated for 72 h in HB101 medium . DNA syn-
thesis was assessed as described . The experiment was done in triplicate . The
data correspond to mean t SD .
' Final dilution of fraction 34 .
Stimulating agent
SAC-blasts
(2,000/well)
Anti-,u blasts
(2,000/well)
cpm
Plain medium 515 t 53 383 t 48
3% human serum 1,780 ± 230 ND
Fraction 34 (1/500)' 2,819 t 337 4,783 t 841
Retinol (3 x 10-7 M) 3,091 t 421 4,375 t 5461618
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is stable under isotonic conditions, but dissociation of the two proteins occurs in
distilled water (13), retinol being retained by RBP To test for the involvement of
the natural carrier system, we have isolated RBP by useofa solid-phase PA column
consisting ofhuman PA attached to CNBr-activated Sepharose (14). Fresh human
serumwaspassed throughthe affinity column, and bound proteins were eluted with
water . The eluted proteins by SDS-PAGE proved to be 85% RBP, with some PA
contamination (Fig. 3) . The ratio of optical absorption at 280 nm to that at 340
nm (0 .7) indicates that most RBP molecules were complexed to retinol (15) . When
assayed in cultures oflymphoblastoid cells (Table 111), theRBP-retinolcomplex (holo-
RBP) showed growth-enhancing activity at the physiological concentration of 40
jig/ml, similar in magnitude to activities ofcrude serum lipids andof commercially
available retinol . DelipidatedRBP (apo-RBP) did not show any growth-enhancing
activity. When the RBP-retinol complex was extracted with methanol/chloroform
and the extract subjected to HPLC on a Cta column, a single peak was observed .
This peak coeluted with fraction 34 (Fig. 1), had similar bioactivity, and showed
thesame molecularion and fragmentation pattern as that ofall-trans retinol(Fig . 2B) .
Comparison of Retinol and Other Retinoids for Bioactivity.
￿
Dose-response curves es-
tablish that all-trans retinol, tested in serum-free HB101 medium, is optimallyactive
at a concentration of 2 x 10-6 to 2.5 x 10'M (Fig. 4), a range corresponding to
the physiological concentration in serum (10-6 M, retinol) (16) . At concentrations
>4 x 10-6 M, retinol is toxic to human B cells in serum-free HB101 (Fig. 4), as
well as in 7% serum-supplemented medium (data not shown) . All-trans retinal is
comparable with retinol in bioactivity at a concentration range of 1-5 x 10-7 molar,
but at 2 x 10 -6 M, it displays toxicity. Retinoic acid, commonly assumed to be the
most active retinol derivative in cell culture (6), has marginal bioactivity on B cells
at 10 -5M (15-25% growth-enhancing capacity as compared with retinol) and is
toxic at higher concentrations . However, ourresultswere not consistent, and in one-
third of the experiments, retinoic acid did not show any growth-enhancing effect .
At concentrations of 4 x 10-6 to 6 x 10 -$ M, there is a noticeable suppression of
thymidine incorporation . When retinoic acidwas admixed to a stimulatory concen-
tration of retinol, the growth stimulatory capacity of the latter was not inhibited
(data not shown) .
FIGURE 3 .
￿
10-15% gradient SDS-PAGE gel ofRBP and
PA . RPBwas purified from humanserum according to ref-
erence 13 . Human PA and molecular weight markers are
shown as reference . The protein bands are visualized by
the silver staining technique .TABLE III
Comparison of Growth-stimulating Effect of Retinol, Holo-, and
apo-RBP on Three Lymphoblastoid Cell lines
Cells of EBV-transformed cell lines 5/2, Mou, and BH were washed and cul-
tured at 2,500/well and incubated for 72 h in serum-free FIB 101 medium . DNA
synthesis was assessed as described. The experiment was done in triplicate. The
data correspond to mean t SD. End concentration of retinol was 10-6 M. 40
Ag/ml of nondelipidated holo-RBP and delipidated apo-RBP were added. holo-
RBP had an absorption ratio from OD34u/OD280 of 0 .7.
RetinolPrevents the Death ofLymphoblastoid Cells in Serum,freeMedium.
￿
The depen-
dency on retinol was studied in detail with the human lymphoblastoid cell line 5/2.
Retinol deprivation did not show aneffect on theviable cell number(Fig. 5)orthymi-
dine uptake (Fig. 6) during the first 24 h. However, on day 2, -30%, and on day
3, -90% of the lymphoblastoid cells in retinol-free medium were dead (trypan
blue-positive cells). When 5/2 cells were harvested after 3 d ofculture in retinol-
containing medium and transferred to retinol-free medium, they showed once again
a precipitous decline in viability and thus were still dependent on retinol (Fig. 6).
Thepopulation crash began 1 d after the cellswere put in retinol-free medium, and
>90% of the cells were dead after 2 d. In contrast, cells seeded again in retinol-
containing medium continued to grow exponentially.
RetinolEnhances theGrowth ofLymphoblastoidCellLines andofActivatedNormal Human
B CellBlasts.
￿
The growth ofsix otherlymphoblastoid cell lines(celllines Mou and
BUCK ET AL.
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M
F[GURE 4. Dose-response curves of
different retinoids. Washed 5/2 cells
(5,000/well) were incubated for 72 h in
HB101 medium with the indicated
amounts of retinoids. DNA synthesis
was measured by [3H]thymidine as
described. The measurements were
done in triplicate. The SDs were never
>15%. Repeat experiments (10 for
retinol and retinoic acid, five for ret-
inal) yielded similar dose-response
curves. One representative experiment
is shown. Where retinol and retinal
gave consistent results, retinoic acid did
not, failing to show any stimulation in
one-third of the experiments.
Stimulating agent 5/2
Growth-stimulating
Mou
cpm
effect
BH
Plain medium 145 t 4 837 t 139 381 t 100
Retinol 3,049 t 356 1,360 ± 21 2,770 t 105
holo-RPB 1,405 t 86 2,263 t 217 5,736 ± 253
apo-RBP 211 t 31 801 t 48 290 f 371620
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vlamesells
BH) (data shown in Table III); cell lines Ducaf, PLH, Thomas, and Pitout (data
not shown), as well as the growth of two Burkitt lymphoma lines (data not shown)
was enhanced 3-20-fold by the addition of 10-6 Mretinol to the serum-free HB 101
medium.
Normal human B cell blasts that were preactivated with anti-/. antibody or SAC
required retinol as acostimulator forgrowth to the same extent as Epstein-Barr-trans-
formed human B cells (Table II).
Discussion
Our main finding is that for optimum growth in cell culture, human lympho-
blastoid cellsrequire retinol and its naturalcarrierproteins, notably retinol-binding
protein. In reaching this conclusion, we have considered thefollowingevidence. First,
retinol occurs in fresh serum in a complex with RBP and PA (9). When retinol is
removed with the serum lipids from the serum proteins by extraction with organic
solvents, the growth-promoting properties of the supplemental serum are lost. But
they are restored when authenticall-trans retinol is mixed back into theresidual serum
proteins. Thus, the effect is associated with retinol and not with an essential fatty
acid. Second, the concentrations of retinol required for optimal growth are similar
to those of fresh serum supplements. Third, all-irans retinol, isolated from human
.TWIN Resnoldert-5
.toad Wowda 1-3
no Rodeoldo "+5
no ReVooldo 1-3
FIGURE 5.
￿
Growth curves of 5/2 cells in suspension culture with and
without retinol. 5/2 cells were washed once and seeded at a density of
300,000/ml in HB101 with or without 10-6 M retinol. The trypan
blue-negative and trypan blue-positive (not shown) cell number ofnine
aliquots was determined every 24 h. Means f SDs are shown.
FIGURE 6.
￿
Blymphoblastoid cells show continueddependency
on retinol. 5/2 cells were washed once andseeded at aconcen-
tration of 300,000/ml in HB101 medium with and without
10-6 M retinol. Thecells of retinol-containing medium were
harvested on day 3, washed once, diluted 1:3 in HB101, and
cultured for another 2 d with or without 10-6 M retinol in
HB101. Triplicate samplesof 100id ofcell suspension were re-
moved daily and pulsed for 6 h with [3H]thymidine. Means
t 'SDs are shown.BUCK ET AL.
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serum, was positively identified by mass spectrometry and was as potent as all-trans
retinol from commercial sources.
The dependency on retinol wasdemonstrated not only with the randomly picked
lymphoblastoid cell line 5/2 but also with several other cell lines, including six other
randomly selected lymphoblastoid and two Burkitt's cell lines. Culture of normal
humanB cellsactivatedwith either anti-p. antibody or heat-inactivatedS. aureus bacteria
were also found to be dependent on retinol in the medium. Thus, our findingmay
have general validity in B cell physiology.
Ouranalysis ofaselected group of retinoids has revealed that all-trans retinol and
all-trans retinal are able to support cell growth at concentrations as low as 2 x
10' M. The physiological concentration of retinol in human serum is -10-6M(9).
Interestingly, all-trans retinoic acid proved to be the least active retinoid, showing
only one-fifth of the activity of retinol at 10-5 M, despite its reputation as a strong
inducer of cell differentiation in cell culture. Perhaps growth promotion and induc-
tion of differentiation are distinct events in the life cycle of a cell, and at a given
time point may even be mutually exclusive events . It is noteworthy that retinoic acid
does not occur in serum at concentrations >10-s M(16, 17), and thus, it is unlikely
that the occasionally observed low stimulatory activity of retinoic acid at a concen-
tration of 10-5 M has any physiological meaning. On the other hand, we can only
state that retinol and retinal represent the active forms of retinoids as extracellular
mediators, but we do not know whether they are converted intracellularly to other
derivatives or isomers, including retinoic acid. It is commonly assumedthat in order
to exert their effects, retinoids have to pass into the cells.
As already alluded to, retinol does not occur in free form in body fluids but is
complexed with RBP, which in turn is bound to tetrameric PA, and it is therefore
assumed that the bioactive form of retinol for extracellular actions is the trimeric
complex. We have previously reported that a protein factor, provisionally named
aBGF (7), and later shown by sequence identity to be the monomer of prealbumin,
is capable ofsupporting B cell growth in suboptimal cultureconditions, and we have
suggestive evidence that RBP in some cultures increases the effectiveness of retinol
(see Table III). These observations are consistent with the view that retinol requires
carrier protein, but our experiments do not resolvethis question since the synthetic
tissue culturemedium used (i.e., medium 1113101), although free of serum, still con-
tains serum proteins. In our experience, albumin preparations used as a supple-
ment of HB101 arecommonly contaminated with PA andRBP Experimentsto define
the role ofthe physiological retinol carrierproteins require homogeneous materials
and are currently in progress.
Ourobservation that retinal acts as growth promoter for human lymphoblastoid
cells has not been reported previously. There is also adearth of information on the
in vivo effects of vitamin A on the immune response, although early observations
in avitaminotic animals have suggested that vitamin A is required for normal lym-
phopoiesis. Reductions in the weights of thymus andlymph nodes in rats (1) as well
as that ofthebursain birds(2) raised on avitamin A-deficient diet are earlymanifesta-
tions of vitamin A deficiency disease, suggesting that lymphopoiesis is dependent
on this vitamin. Frequent infections in such animals further suggest a malfunction
of the immune system. Germ-free rats fed with avitamin A-deficient diet have far
fewer complications and attain a nearly normal life span, as compared with their1622
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vitamin A-deficient littermates kept under conventional conditions, which do not
survive thefirst 2 mo oflife (3). Studies in chicks made vitaminA deficient by main-
taining them from hatching on a diet of retinoic acid showed drastic reductions in
the growth of the thymus and bursa (2). Thus, retinoic acid is inferior to retinol
in maintenance of lymphoid tissue in chicks.
Systematic studies of the proliferative effect of vitamin A on cultured B lympho-
cytes are nonexistant. To place our findings in perspective with the known vitamin
A physiology, one must thereforelook farther afield. Best studied are epithelial cell
cultures, since it has been known since the work ofWolbach and Howe (1)that vitamin
A affects keratinocytes in vivo. Tissue explants and epithelial cell lines (6, 18) are
regulated by retinoids. Besides cell growth, which requires retinoids, and delipidated
serum as a medium supplement, the differentiation state of epithelial cells appears
to be affected by vitamin A as well.
In other examples of cellular systems, where retinoids either enhance growth or
induce differentiation, retinoic acid was found to be more potent than retinol or
retinal (6). Cases in point are: (a) retinoic acid increases total DNA and RNA in
newborn mouse epidermal cells in culture at a concentration of 4 x 10-1° M (18);
(b) during embryogenesis, formation of aphysiological retinoic acid gradient is deci-
sive in determining the anterior/posterior orientation of the chicken wing (19, 20);
(c) retinoic acid promotes differentiation in embryonal carcinomacells (21), in HL-
60 cells (22, 23), and numerous metaplasias in squamous epithelia (24); and (d)
several closely related nuclear receptor molecules have been described for retinoic
acid (25-27), and none so far for retinol or retinal.
One cellular system known to be controlled by retinol and where retinoic acid
appears to play a subordinate role is spermatogenesis (28, 29). In this respect, our
finding that B cell growth is dependent on vitamin A has its closest precedent in
spermatogenesis. In both instances, retinoic acid is unable to substitute fortheretinol
or retinal forms of vitamin A.
Summary
When EBVtransformed human B cells are removed from conventional cell cul-
tures, washed, and seeded at a low cell density in serum-free medium, their growth
potential is greatly diminished. Fresh serum restores the growth of low density B
cell cultures. We have traced this restorative effect to an essential factor present in
thelipid fraction ofserum andhave identified it as all-trans retinol. The identification
is based on the close similarities of the factor isolated from serum with authentic
all-trans retinol as revealed by mass spectrometry, HPLC chromatography, and the
ability to stimulate the growth of lymphoblastoid cells in the bioassay. Retinol is
active at concentrations equal to its concentration in serum. Retinol is also a re-
quirement for growth in suspension cultures at cell densities of 3 x 105/ml. Cells
removed at any time from such exponentially growing cultures and transferred to
retinol-free medium cease to grow and consequently die, whereas in the continued
presence of retinol, cell growth is unabated. All-trans retinal can substitute for retinol,
but retinoic acid fails to stimulate the growth of lymphoblastoid cells at physiolog-
ical concentrations. Normal human B lymphocytes also require retinol as a costimu-
latorof proliferation after activation by anti-Et antibody or Staphylococcus aureus (Cowan
strain) bacteria. In serum, retinol is bound to retinol-binding protein, whichin turnBUCK ET AL.
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forms a complex with prealbumin. Accordingly, we find that B cells respond to retinol
bound to its physiological serum carrier, retinol-binding protein. In conclusion, human
B cells are critically dependent for optimal growth in cell culture on an external
supply of retinol.
We thank Dr. E. Levi for performing SDS-PAGE gels and HPLC chromatography; Dr. T.
Pettersson, Karolinska Institutes, Stockholm, Sweden, for a gift of RBP-conjugated beads;
and B. Forbes for preparation of the manuscript.
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